Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry.
about
Deep and quantitative top-down proteomics in clinical and translational researchArizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading.High-Resolution Group Quantization Phase Processing Method in Radio Frequency Measurement Range.Comparative top down proteomics of peripheral blood mononuclear cells from kidney transplant recipients with normal kidney biopsies or acute rejection.Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsProgress in Top-Down Proteomics and the Analysis of Proteoforms.High resolution metabolomics technology reveals widespread pathway changes of alcoholic liver disease.LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Development of Passive Immunotherapies for Synucleinopathies.Do the complementarities of electrokinetic and chromatographic procedures represent the "Swiss knife" in proteomic investigation? An overview of the literature in the past decade.Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and α-synuclein toward in-vivo analysis.Toward best practices in data processing and analysis for intact biotherapeutics by MS in quantitative bioanalysis.Fluorescent Probe DCVJ Shows High Sensitivity for Characterization of Amyloid β-Peptide Early in the Lag Phase.Top-Down Proteomics: Ready for Prime Time?MS-based methods for biomarkers of Parkinson's disease: what is the future?How many human proteoforms are there?The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.Top-down proteomics: Where we are, where we are going?A whole-molecule immunocapture LC-MS approach for the in vivo quantitation of biotherapeutics.Similar α-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls.Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration.
P2860
Q34969457-108EBFB5-877C-4C4C-A0CA-081962AA9F25Q36121377-D04474EC-C595-4284-B5ED-EC45EF830487Q36659034-5BA2669D-E5F3-44B9-9AD7-80B5F5C67D75Q37076371-186C71A4-9C3F-4BE2-B017-30AEE3805D13Q37116032-90763168-492C-4F34-8796-81026600BA22Q37566684-365DD923-9A4F-429F-848F-BF8091350549Q37730532-FD9AB4B3-D98F-4F24-BCC4-010BADA4068FQ38454397-4B4E84EE-6720-4332-BDB6-65013B41F881Q38571078-3C6798B3-58B8-4B31-9109-5E50017A85FAQ38669105-CC272A1F-133E-4094-88DE-F7C59EC7EB65Q38679627-0D412ACA-F368-4EAC-A0D9-CB9FC3D7F331Q39107333-459EEBC1-CEB2-46E9-B148-C213C8C1AD98Q41529132-7A8F481E-0B9D-41F2-AB07-07424B872BA8Q46266933-CA5DED51-A7CF-41EB-A03E-3EDCA2C879FEQ47368517-4478B875-744D-4399-92FA-EE744E41AD9AQ47822768-9DA5FE43-08D8-4939-92D6-BDC89C59015AQ48262177-6DB8D94D-784A-4BFE-A06D-A7F25DF76166Q48633515-AA5692FA-15CF-4B74-AB84-C25F98AC4B96Q50001631-4BDD493A-5209-454F-B6BA-1C19789E76E4Q51082125-2A199596-8B39-4844-AD73-31BCE145836AQ51141328-FDB55686-B054-4ECD-8B54-C9B5B0FF89DCQ51525919-C0AD19A0-FA4E-42C3-AF66-F86096872879Q51691895-0CEFD5C8-B873-4F0F-BBE5-C8675DB037B9Q55152170-75F4CB64-822B-44E1-9339-281DCF1F556F
P2860
Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quantitative measurement of in ...... act protein mass spectrometry.
@ast
Quantitative measurement of in ...... act protein mass spectrometry.
@en
type
label
Quantitative measurement of in ...... act protein mass spectrometry.
@ast
Quantitative measurement of in ...... act protein mass spectrometry.
@en
prefLabel
Quantitative measurement of in ...... act protein mass spectrometry.
@ast
Quantitative measurement of in ...... act protein mass spectrometry.
@en
P2093
P2860
P356
P1433
P1476
Quantitative measurement of in ...... act protein mass spectrometry.
@en
P2093
Anthony Major
John F Kellie
John W Ryder
Kalpana Merchant
Michael D Knierman
Richard E Higgs
P2860
P2888
P356
10.1038/SREP05797
P407
P577
2014-07-23T00:00:00Z
P5875
P6179
1036900483